- Zacks•9 hours ago
Here we have three pharma companies that are set to report fourth-quarter results on Feb 21. Let's see how things are shaping up for this quarter.
- GlobeNewswire•3 days agoMomenta Pharmaceuticals Announces Time Change for Fourth Quarter and Year End 2016 Financial Results Conference Call and Webcast
CAMBRIDGE, Mass., Feb. 17, 2017-- Momenta Pharmaceuticals, Inc., announced today that is has changed the time for its fourth quarter and year end 2016 earnings conference call and webcast. Momenta will ...
- GlobeNewswire•3 days agoMomenta Pharmaceuticals Announces FDA Warning Letter to Contracted Glatopa® (glatiramer acetate injection) Fill/Finish Manufacturer
Approval of the Glatopa 40 mg ANDA will be dependent on resolution of Pfizer facility compliance issues. Warning letter does not restrict the production or shipment of Glatopa 20 mg. CAMBRIDGE, Mass., ...
MNTA : Summary for Momenta Pharmaceuticals, Inc. - Yahoo Finance
Momenta Pharmaceuticals, Inc. (MNTA)
NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
|Bid||16.50 x 500|
|Ask||18.00 x 100|
|Day's Range||18.60 - 19.25|
|52 Week Range||7.86 - 19.90|
Trade prices are not sourced from all markets
|PE Ratio (TTM)||-14.18|
|Dividend & Yield||N/A (N/A)|
|1y Target Est||N/A|